Skip to main content

BSC’s appeal to Reverse the $18.5 Million TVM Verdict Denied

BSC’s appeal to Reverse the $18.5 Million TVM Verdict Denied

Introduction

Boston Scientific Corp.’s appeal to reverse a 2014 transvaginal mesh verdict was declined by the federal court. A total of $18.5 million was awarded by the jury belonging to the U.S. District Court, Southern District of West Virginia to the four plaintiffs named in the litigation, who suffered serious complications following the implantation of BSC’s Obtryx transvaginal mesh devices.

BSC was successful in settling two of the cases out of court for undisclosed amounts since the trial, but it went ahead and appealed the remaining awards to the 4th U.S. Circuit Court of Appeals. This appeal was denied as the Appeals Court disagreed with the company’s contentions, finding that Boston Scientific had failed to provide any evidence of prejudice or confusion.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Links Roundup Chemical to Long-Term Brain Damage

Categories: Roundup

A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!